NASDAQ · Biotechnology

Equillium Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.52

+0.04 (+2.70%)

As of Feb 8, 2:12 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 80%

Hold 2 20%

Sell 0 0%

Price Target

Analyst Price Target +1,673.7% upside

Low Target $18.17

Average Target $26.96

High Target $35.46

Current Price $1.52

Current
$1.52

Target
$26.96

$18.17 $26.96 avg $35.46

Scenario Analysis

Bear Case

$18.17

1,095.4%

Low target

Base Case

$26.96

+1,673.7%

Avg target

Bull Case

$35.46

+2,232.9%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$26.28

-94.2% from high

52-Week Low

$16.46

+-90.8% from low

Target vs 52W High

$26.96

+2.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%